AAAAAA

   
Results: 1-13 |
Results: 13

Authors: Belldegrun, A Tso, CL Zisman, A Naitoh, J Said, J Pantuck, AJ Hinkel, A de Kernion, J Figlin, R
Citation: A. Belldegrun et al., Interleukin 2 gene therapy for prostate cancer: Phase I clinical trial andbasic biology, HUM GENE TH, 12(8), 2001, pp. 883-892

Authors: Rodriguez, J Romaguera, JE Katz, RL Said, J Cabanillas, F
Citation: J. Rodriguez et al., Primary effusion lymphoma in an HIV-negative patient with no serologic evidence of Kaposi's sarcoma virus, LEUK LYMPH, 41(1-2), 2001, pp. 185-189

Authors: Lin, S Hirschowitz, SL Williams, C Shintako, P Said, J Rao, JY
Citation: S. Lin et al., Cytokeratin 20 as an immunocytochemical marker for detection of urothelialcarcinoma in atypical cytology: Preliminary retrospective study on archived urine slides., CANCER DET, 25(2), 2001, pp. 202-209

Authors: Amara, N Palapattu, GS Schrage, M Gu, ZN Thomas, GV Dorey, F Said, J Reiter, RE
Citation: N. Amara et al., Prostate stem cell antigen is overexpressed in human transitional cell carcinoma, CANCER RES, 61(12), 2001, pp. 4660-4665

Authors: Thomas, GV Schrage, MI Rosenfelt, L Kim, JH Salur, G deKernion, JB Dorey, F Said, J Reiter, RE
Citation: Gv. Thomas et al., Preoperative prostate needle biopsy p27 correlates with subsequent radicalprostatectomy p27, gleason grade and pathological stage, J UROL, 164(6), 2000, pp. 1987-1991

Authors: Smith, EA Frankenburg, EP Goldstein, SA Koshizuka, K Elstner, E Said, J Kubota, T Uskokovic, M Koeffler, HP
Citation: Ea. Smith et al., Effects of long-term administration of vitamin D-3 analogs to mice, J ENDOCR, 165(1), 2000, pp. 163-172

Authors: Berger, O Gan, XH Gujuluva, C Burns, AR Sulur, G Stins, M Way, D Witte, M Weinand, M Said, J Kim, KS Taub, D Graves, MC Fiala, M
Citation: O. Berger et al., CXC and CC chemokine receptors on coronary and brain endothelia, MOL MED, 5(12), 1999, pp. 795-805

Authors: Elstner, E Campbell, MJ Munker, R Shintaku, P Binderup, L Heber, D Said, J Koeffler, HP
Citation: E. Elstner et al., Novel 20-epi-vitamin D-3 analog combined with 9-cis-retinoic acid markedlyinhibits colony growth of prostate cancer cells, PROSTATE, 40(3), 1999, pp. 141-149

Authors: Koike, M Koshizuka, K Kawabata, H Yang, R Taub, HE Said, J Uskokovic, M Tsuruoka, N Koeffler, HP
Citation: M. Koike et al., 20-cyclopropyl-cholecalciferol vitamin D-3 analogs: A unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines, ANTICANC R, 19(3A), 1999, pp. 1689-1697

Authors: Koshizuka, K Kubota, T Said, J Koike, M Binderup, L Uskokovic, M Koeffler, HP
Citation: K. Koshizuka et al., Combination therapy of a vitamin D-3 analog and all-trans-retinoic acid: Effect on human breast cancer in nude mice, ANTICANC R, 19(1A), 1999, pp. 519-524

Authors: Craft, N Chhor, C Tran, C Belldegrun, A DeKernion, J Witte, ON Said, J Reiter, RE Sawyers, CL
Citation: N. Craft et al., Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step process, CANCER RES, 59(19), 1999, pp. 5030-5036

Authors: Kawano, S Miller, CW Gombart, AF Bartram, CR Matsuo, Y Asou, H Sakashita, A Said, J Tatsumi, E Koeffler, HP
Citation: S. Kawano et al., Loss of p73 gene expression in leukemias/lymphomas due to hypermethylation, BLOOD, 94(3), 1999, pp. 1113-1120

Authors: Yang, R Nakamaki, T Lubbert, M Said, J Sakashita, A Freyaldenhoven, BS Spira, S Huynh, V Muller, C Koeffler, P
Citation: R. Yang et al., Cyclin A1 expression in leukemia and normal hematopoietic cells, BLOOD, 93(6), 1999, pp. 2067-2074
Risultati: 1-13 |